INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-1168902334 FDA]( "Accelerate FDA Approval With Fast Track Designation")
Accelerate FDA Approval With Fast Track DesignationLearn how Fast Track Designation streamlines the FDA review process and offers faster approval for serious diseases or life-threatening conditions.
-
![GettyImages-1600718991-gloved-hand-labcoat-scientist-handshake]( "CDMOs - Key Collaborators In Streamlining Drug Development")
CDMOs - Key Collaborators In Streamlining Drug DevelopmentAccelerating biologics development requires more than speed. Discover how the right CDMO partnership can streamline processes and help you reach the market faster without sacrificing control.
-
![GettyImages-1162413622-vials-organs-scientist-dna-strand]( "A Novel Patient-Derived Colorectal Cancer Organoid Platform")
A Novel Patient-Derived Colorectal Cancer Organoid PlatformPatient-derived organoids are revolutionizing drug discovery by mimicking tumors and predicting therapeutic efficacy. Discover a scalable bioprocess that enhances reproducibility and cost-effectiveness to pave the way for broader adoption.
-
![antibody molecules-GettyImages-2165626333]( "ADC Development Grows More Complex — SPR Insights Bring Clarity")
ADC Development Grows More Complex — SPR Insights Bring ClarityExplore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.
-
New Approaches To Tailored Release Profiles7/7/2025
Tailored drug release is evolving from formulation tactic to precision therapy strategy, optimizing timing, site, and rate of delivery for improved patient outcomes.
-
Advancing GLP-1 Analog Drug Development Using A Variety Of Techniques6/27/2025
Discover how SEC-MALS reveals the aggregation behavior of GLP-1 analogs like semaglutide and liraglutide, which are critical for ensuring the stability, efficacy, and safety of peptide therapeutics.
-
Sustainability In On-Body Delivery System Platforms7/2/2026
Explore how our on-body delivery system supports high-volume biologic delivery by balancing usability, patient needs, and sustainability through research-driven design.
-
Episodic Vs. Continuous Readiness: Which Operating Model Is Carrying Your Biotech Forward?5/11/2026
Transitioning from episodic audit prep to continuous readiness protects clinical timelines. Evaluate your quality operating model to support scalable growth today.
-
Overcoming Challenges To High-Concentration Formulation Development3/25/2025
Explore how the S-HiCon™ platform optimizes high-concentration therapeutic antibody formulations, overcoming stability and manufacturability challenges to deliver safe, effective therapies.
DRUG DEVELOPMENT SOLUTIONS
-
![GettyImages-2163606903-gloves-pipet-cell-culture-assay]( "Immunoassays And LC-MS")
Explore immunoassays and LC-MS kits for over 30 clinical areas, each with detailed specifications and broad sample compatibility for precise, high-throughput biomarker analysis.
-
![Scientist in lab GettyImages-872025342]( "Drug-Drug Interaction (DDI) Studies")
Learn how an innovative development platform with the unique ability to fully integrate DDI studies accelerate timelines and improve the likelihood of downstream success.
-
Access all the service, support, and performance maintenance options you need for uninterrupted performance – giving your lab more control over your service, maintenance costs, and enabling you to optimize your laboratory productivity.
-
![GettyImages-899692870-lab-cleanroom-research-microscope]( "Peptide Development Strategies")
Peptides occupy a therapeutic niche between small molecules and large biologics. We understand the fundamental physiological challenges to peptide delivery and that there is no “one-size-fits-all” approach for formulation design.
-
![GettyImages-2187764040-cell-culture-testing-manufacturing-in-lab]( "Laboratory Services")
Integrated lab services deliver method development, validation, and testing across modalities, supporting quality, compliance, and formulation progress from early development to commercialization.
